These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5255181)

  • 21. A pilot study of AL-1612 in chronic schizophrenics.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Dec; 13(12):743-6. PubMed ID: 5001743
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
    Dehnel LL; Vestre ND; Schiele BC
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of schizophrenics with perphenazine enanthate].
    Madsen A; Sorensen J
    Nord Psykiatr Tidsskr; 1971; 25(5):475-8. PubMed ID: 5144306
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of the therapeutic effect of triperidol with perphenazine in schizophrenia].
    Náhunek K; Hádlik J; Svestka J; Rodová A; Vanýsek J
    Cesk Psychiatr; 1969 Oct; 65(5):281-9. PubMed ID: 5363280
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics.
    Collins AD; Dundas J
    Br J Psychiatry; 1967 Dec; 113(505):1425-9. PubMed ID: 4865295
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the therapeutic effect of flupenthixol and perphenazine in schizophrenia.
    Náhunek K; Svestka J; Rodová A
    Act Nerv Super (Praha); 1970; 12(3):247-8. PubMed ID: 5457440
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controlled trial of perphenazine in the treatment of chronic schizophrenias].
    Sutter JM; Scotto JC; Luccioni H; Dufour H; Alerini P
    Encephale; 1971; 60(2):136-64. PubMed ID: 5564325
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the question of differences between therapeutic responses after particular neuroleptics in comparison to perphenazine in schizophrenics (author's transl)].
    Náhunek K; Svestka J; Cesková E
    Cesk Psychiatr; 1981 Feb; 77(1):25-30. PubMed ID: 6113897
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic schizophrenia treated with depot perphenazine].
    Petersson H; Remvig J; Sorensen B
    Nord Psykiatr Tidsskr; 1971; 25(4):303-8. PubMed ID: 5154114
    [No Abstract]   [Full Text] [Related]  

  • 31. Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
    Svestka J; Cesková E; Rysánek R; Náhunek K
    Act Nerv Super (Praha); 1989 Dec; 31(4):276-7. PubMed ID: 2576922
    [No Abstract]   [Full Text] [Related]  

  • 32. [A recent clinical trial of perphenazine].
    Scotto JC
    Psychopharmacologie; 1971; ():83-5. PubMed ID: 5162010
    [No Abstract]   [Full Text] [Related]  

  • 33. [The serum perphenazine level in patients with schizophrenia and the results of treatment].
    Nurowska K; Welbel L; Lipska B; Szukalski B
    Psychiatr Pol; 1987; 21(1):20-5. PubMed ID: 3615673
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term study of molindone hydrochloride in chronic schizophrenics.
    Kellner R; Rada RT; Egelman A; Macaluso B
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):686-94. PubMed ID: 825355
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical comparison of methophenazine and perphenazine in schizophrenia. A controlled study. Effects on the photomyoclonic threshold].
    Náhunek K; Svestka J; Misurec J
    Act Nerv Super (Praha); 1967 Nov; 9(4):404-5. PubMed ID: 4889075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients. A controlled study.
    Svestka J; Rodovà A; Nàhunek K
    Act Nerv Super (Praha); 1973 May; 15(2):103-4. PubMed ID: 4591602
    [No Abstract]   [Full Text] [Related]  

  • 39. Biphasic drugs in the treatment of depression with anxiety.
    Krakowski AJ
    Psychosomatics; 1969; 10(3):7-11. PubMed ID: 5822699
    [No Abstract]   [Full Text] [Related]  

  • 40. Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients.
    Sterlin C; Ban TA; Lehmann HE; Jarrold L
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):417-9. PubMed ID: 4558247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.